Coumarin is a classic sweet hay-like aroma chemical found naturally in botanicals such as tonka and cinnamon-related materials and appears in the AromaForge archive as a constituent of cassia and Austrian hay. Its evidence profile is unusual for an aroma constituent because the safety and metabolism literature is much stronger than any wellness literature: public sources emphasize oral hepatotoxicity risk at higher exposure, species differences in metabolism, and regulatory tolerable-intake framing. For archive use, coumarin is best described as a high-recognition fragrance constituent with strong identity data and strong safety context, while avoiding therapeutic claims.
Aroma and practical use
- Use the recorded sweet, hay-like, tonka-like, vanillic, almond-like descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A randomized clinical trial summary cited in PubMed followed 231 patients receiving a coumarin-containing oral medicine and found no evidence that the studied CYP2A6 polymorphisms explained coumarin-associated liver dysfunction.
A randomized clinical trial summary cited in PubMed followed 231 patients receiving a coumarin-containing oral medicine and found no evidence that the studied CYP2A6 polymorphisms explained coumarin-associated liver dysfunction.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
A dermatology study reported that highly pure coumarin showed no clear T-cell activation or allergic contact dermatitis response in its mouse fragrance-allergy model, supporting the view that impurity profile matters for sensitization findings.
A dermatology study reported that highly pure coumarin showed no clear T-cell activation or allergic contact dermatitis response in its mouse fragrance-allergy model, supporting the view that impurity profile matters for sensitization findings.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A large fragrance-label review found coumarin sensitization frequencies around 0.4% in patch-tested patients, placing it among lower-frequency but still relevant fragrance allergens.
A large fragrance-label review found coumarin sensitization frequencies around 0.4% in patch-tested patients, placing it among lower-frequency but still relevant fragrance allergens.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedEFSA's public scientific opinion and the Australian TGA review both frame 0.1 mg/kg body weight per day as the relevant tolerable daily intake benchmark discussed for coumarin exposure.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
The RIFM safety assessment states that coumarin is rapidly absorbed, that human metabolism favors 7-hydroxylation, and that hepatotoxicity reports exist even though species responses differ materially from rodents.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
The TGA topical review explicitly noted that a 0.3% body-use level from the IFRA standard could exceed the tolerable daily limit in sunscreen-style use scenarios, reinforcing that coumarin risk is exposure-dependent.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
species dependent metabolism
RIFM and EFSA-linked safety summaries describe human coumarin metabolism as favoring detoxifying 7-hydroxylation, while rodents rely more on 3,4-epoxidation and downstream hepatotoxic intermediates.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Most robust coumarin evidence concerns oral metabolism and safety rather than inhalation or fragrance-benefit outcomes.
- No constituent-specific consumer-topical exposure model for AromaForge formulations was calculated in this pass.
- The archive should avoid implying that coumarin's presence in aromatic materials confers therapeutic benefit.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.